摘要：TNF-α作为治疗包括炎症性肠病在内的炎症紊乱性疾病的治疗靶标已被广泛接受。 TNF-α抑制剂英夫利昔单抗、阿达木单抗、戈利木单抗以及聚乙二醇结合赛妥珠单抗均已由FDA批准用于IBD的治疗。因此，深入了解TNF？α单克隆抗体的作用机制以及安全有效的用于IBD的治疗将为IBD患者带来更多获益。
注：因版权方要求，不能公开全文，如需全文，请咨询杂志社
热门期刊服务
The Journal of China Universities of Posts and Telecommunications Control Theory and Technology Journal of Semiconductors Research in Astronomy and Astrophysics Transactions of Nonferrous Metals Society of China China Petroleum Processing Petrochemical Technology Tsinghua Science and Technology High Technology Letters Earthquake Engineering and Engineering Vibration Journal of Wuhan University of Technology Communications in Theoretical Physics Hepatobiliary Pancreatic Diseases International